After its ‘near-death experience’ where does Unilever go from here?

and Procter & Gamble, meanwhile, have surged about 65 per cent and 80 per cent over the past half-decade.

The company told analysts on a trading update call in October that it was successfully pushing prices up across all its regions last year, amid a global spike in inflation for raw materials. But it’s come at a cost, with sales volumes falling across There were also major question marks over the growth GSK’s consumer products could inject into Unilever. While GSK said last weekend that it was “confident” the business could deliver 4-6 per cent sales growth over the medium term, that is materially higher than the 2.5-3.5 per cent GSK had guided as this product category’s growth prospects at a broker conference last June, analysts said.

Might the focus now turn to divestments - such as its food and refreshments division - to unlock value? After all, it sold its tea business, including theMartin Deboo

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Unilever chief under pressure after company walks away from GSK dealInvestor dissent forces company to drop bid for GlaxoSmothKline’s consumer products unit
Source: IrishTimesBiz - 🏆 6. / 77 Read more »

Unilever won't raise rejected bid for GSK consumer armUnilever has effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise its £50 billion offer that GSK previously rejected.
Source: RTEbusiness - 🏆 16. / 61 Read more »